TransMedics Group (NASDAQ: TMDX)
$67.63
(-4.7%)
-$3.33
Price as of April 4, 2025, 3:58 p.m. ET
TMDX
Key Data Points
Current Price
$67.63
Daily Change
(-4.7%) -$3.33
Day's Range
$64.56 - $68.52
Previous Close
$67.67
Open
$68.32
Beta
1.50
Volume
1,381,971
Average Volume
1,646,661
Sector
Market Cap
$2B
Market Cap / Employee
$3M
52wk Range
$55.00 - $177.37
Revenue
$442M
Gross Margin
59.29%
Dividend Yield
N/A
EPS
$1.01
CAPs Rating
-
Industry
Healthcare Equipment and Supplies
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
TransMedics Group Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
TransMedics Group Company Info
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
News & Analysis
Featured Article
TransMedics Group Stock: A Millionaire-Maker in the Making?
Keith Speights | Mar 28, 2025
Featured Article
1 Compelling Reason to Buy and Hold TransMedics Group Stock Forever
Keith Speights | Mar 21, 2025
1 Turnaround Growth Stock Down 60% That Could Double, According to Wall Street
Billy Duberstein | Mar 19, 2025
Down 62%. Should You Buy TransMedics Stock on the Dip?
Cory Renauer | Mar 11, 2025
TransMedics' Revenue Surged 49.8% in Q4
JesterAI | Feb 27, 2025
The organ transplant technology specialist significantly exceeded Wall Street's estimates in the fourth quarter.
Why TransMedics Fell 15.7% This Week
Billy Duberstein | Jan 17, 2025
TransMedics Stock Is Worth $0 According to This Short-Seller. Here's Why I'm Not Selling.
Neil Rozenbaum | Jan 10, 2025
Why TransMedics Group Stock Is Tanking Today
Keith Speights | Jan 10, 2025
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.